crisprQTL mapping as a genome-wide association framework for cellular genetic screens
Molly J. GasperiniiD, Andrew J. HilliD, José L. McFaline‐FigueroaiD, Beth MartiniD, Cole TrapnelliD, Nadav AhituviD, Jay ShendureiD
Abstract
Expression quantitative trait locus (eQTL) and genome-wide association studies (GWAS) are powerful paradigms for mapping the determinants of gene expression and organismal phenotypes, respectively. However, eQTL mapping and GWAS are limited in scope (to naturally occurring, common genetic variants) and resolution (by linkage disequilibrium). Here, we present crisprQTL mapping, a framework in which large numbers of CRISPR/Cas9 perturbations are introduced to each cell on an isogenic background, followed by single-cell RNA-seq (scRNA-seq). crisprQTL mapping is analogous to conventional human eQTL studies, but with individual humans replaced by individual cells; genetic variants replaced by unique combinations of unlinked guide RNA (gRNA)-programmed perturbations per cell; and tissue-level RNA-seq of many individuals replaced by scRNA-seq of many cells. By randomly introducing gRNAs, a single population of cells can be leveraged to test for association between each perturbation and the expression of any potential target gene, analogous to how eQTL studies leverage populations of humans to test millions of genetic variants for associations with expression in a genome-wide manner. However, crisprQTL mapping is neither limited to naturally occurring, common genetic variants nor by linkage disequilibrium. As a proof-of-concept, we applied crisprQTL mapping to evaluate 1,119 candidate enhancers with no strong a priori hypothesis as to their target gene(s). Perturbations were made by a nuclease-dead Cas9 (dCas9) tethered to KRAB, and introduced at a mean allele frequency of 1.1% into a population of 47,650 profiled human K562 cells (median of 15 gRNAs identified per cell). We tested for differential expression of all genes within 1 megabase (Mb) of each candidate enhancer, effectively evaluating 17,584 potential enhancer-target gene relationships within a single experiment. At an empirical false discovery rate (FDR) of 10%, we identify 128 cis crisprQTLs (11%) whose targeting resulted in downregulation of 105 nearby genes. crisprQTLs were strongly enriched for proximity to their target genes (median 34.3 kilobases (Kb)) and the strength of H3K27ac, p300, and lineage-specific transcription factor (TF) ChIP-seq peaks. Our results establish the power of the eQTL mapping paradigm as applied to programmed variation in populations of cells, rather than natural variation in populations of individuals. We anticipate that crisprQTL mapping will facilitate the comprehensive elucidation of the cis-regulatory architecture of the human genome.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 4
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- CRISPRi perturbation screens and eQTLs provide complementary and distinct insights into GWAS target genes
Samuel Ghatan, Jasper Panten, … Tuuli Lappalainen·bioRxiv·May 5, 2025
- sc-pcQTL: hurdle-based co-expression modeling for multi-gene QTL mapping in single-cell RNA-seq data
Junkai Zhang, Yi Huang, … Wei Zhou·bioRxiv·Aug 23, 2026
- Linking genotypes with multiple phenotypes in single-cell CRISPR screens
Lin Yang, Yuqing Zhu, … Wei Li·Genome biologyPeer-reviewed·Jan 24, 2020
- Optimising expression quantitative trait locus mapping workflows for single-cell studies
Anna S. E. Cuomo, Giordano Alvari, … Marc Jan Bonder·Genome biologyPeer-reviewed·Jun 24, 2021
- Efficient and accurate mixed model association tool for single-cell eQTL analysis
Wei Zhou, Anna S. E. Cuomo, … Benjamin M. Neale·medRxiv·May 15, 2024
- Whole-organism eQTL mapping at cellular resolution with single-cell sequencing
Eyal Ben‐David, James Boocock, … Leonid Kruglyak·eLifePeer-reviewed·Mar 18, 2021